MGA has also been identified as a common genetic alteration in hematological neoplasms, including acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), natural killer/T-cell lymphoma, B-cell acute lymphoblastic leukemia (B-ALL), and T-cell acute lymphoblastic leukemia (T-ALL) [13–18]. The gene discussed is MGA; the disease is acute myeloid leukemia.